Andersons pediatric cardiology 1672
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.7 KB, 3 trang )
cardiomyopathy.Circulation.
2003;107(22):2850–2856.
138.HinsonJT,ChopraA,LoweA,etal.Integrative
analysisofPRKAG2cardiomyopathyiPSand
microtissuemodelsidentifiesAMPKasa
regulatorofmetabolism,Survival,andfibrosis.
CellRep.2016;17(12):3292–3304.
139.KimM,HunterRW,Garcia-MenendezL,etal.
Mutationinthegamma2-subunitofAMPactivatedproteinkinasestimulates
cardiomyocyteproliferationandhypertrophy
independentofglycogenstorage.CircRes.
2014;114(6):966–975.
140.ZhangLP,HuiB,GaoBR.Highriskofsudden
deathassociatedwithaPRKAG2-related
familialWolff-parkinson-whitesyndrome.J
Electrocardiol.2011;44(4):483–486.
141.AkmanHO,SampayoJN,RossFA,etal.Fatal
infantilecardiacglycogenosiswith
phosphorylasekinasedeficiencyandamutation
inthegamma2-subunitofAMP-activated
proteinkinase.PediatrRes.2007;62(4):499–
504.
142.SternickEB,OlivaA,GerkenLM,etal.
Clinical,electrocardiographic,and
electrophysiologiccharacteristicsofpatients
withafasciculoventricularpathway:theroleof
PRKAG2mutation.HeartRhythm.
2011;8(1):58–64.
143.LimongelliG,Tome-EstebanM,Dejthevaporn
C,etal.Prevalenceandnaturalhistoryofheart
diseaseinadultswithprimarymitochondrial
respiratorychaindisease.EurJHeartFail.
2010;12(2):114–121.
144.BatesMG,NesbittV,KirkR,etal.
Mitochondrialrespiratorychaindiseasein
childrenundergoingcardiactransplantation:a
prospectivestudy.IntJCardiol.
2012;155(2):305–306.
145.Yaplito-LeeJ,WeintraubR,JamsenK,etal.
Cardiacmanifestationsinoxidative
phosphorylationdisordersofchildhood.J
Pediatr.2007;150(4):407–411.
146.ScagliaF,TowbinJA,CraigenWJ,etal.Clinical
spectrum,morbidity,andmortalityin113
pediatricpatientswithmitochondrialdisease.
Pediatrics.2004;114(4):925–931.
147.DebrayFG,LambertM,ChevalierI,etal.Longtermoutcomeandclinicalspectrumof73
pediatricpatientswithmitochondrialdiseases.
Pediatrics.2007;119(4):722–733.
148.HolmgrenD,WahlanderH,ErikssonBO,etal.
Cardiomyopathyinchildrenwithmitochondrial
disease;clinicalcourseandcardiological
findings.EurHeartJ.2003;24(3):280–288.
149.VydtTC,deCooRF,SolimanOI,etal.Cardiac
involvementinadultswithm.3243a>GMELAS
genemutation.AmJCardiol.2007;99(2):264–
269.
150.MalfattiE,LaforetP,JardelC,etal.Highriskof
severecardiacadverseeventsinpatientswith
mitochondrialm.3243a>Gmutation.Neurology.
2013;80(1):100–105.
151.ChildJS,PerloffJK,BachPM,etal.Cardiac
involvementinFriedreich'sataxia:aclinical
studyof75patients.JAmCollCardiol.
1986;7(6):1370–1378.
152.IsnardR,KalotkaH,DurrA,etal.Correlation
betweenleftventricularhypertrophyandGAA
trinucleotiderepeatlengthinFriedreich'sataxia.
Circulation.1997;95(9):2247–2249.
153.CasazzaF,MorpurgoM.Thevaryingevolution
ofFriedreich'sataxiacardiomyopathy.AmJ
Cardiol.1996;77(10):895–898.
154.CampuzanoV,MonterminiL,MoltoMD,etal.
Friedreich'sataxia:autosomalrecessivedisease
causedbyanintronicGAAtripletrepeat
expansion.Science.1996;271(5254):1423–1427.
155.DurrA,CosseeM,AgidY,etal.Clinicaland
geneticabnormalitiesinpatientswith
Friedreich'sataxia.NEnglJMed.
